CRISPR, the Nobel Prize winning technology, is revolutionizing genetic science. but its potential goes far beyond medicine. As we gain the ability to edit the human genome, new questions emerge: Who gets access? How do we decide what should be changed? And how do we harness a tool that could reshape society itself? We discuss the future of genetic modifications with Professor Dov Greenbaum. With a Ph.D in genetics from Yale University, a Juris Doctorate from U.C. Berkeley, and Post-Doctorate from Stanford University, his expertise perfectly bridges genetics and law. Hosts: Noa Mimram and Shachar Farber Research partner: Shira Yaniv Executive Producer: Ayelet Triest Editor: Ben Shani Professional guidance: Mrs. Inbar Carmel and Professor Dov Greenbaum